Skip to main content

$0.700 0.005 (0.72%)

High

$0.72

Low

$0.70

Trades

33

Turnover

$39,512

Volume

56,305
30 June 2023 at 4:10pm
Register to track CU6 and receive email alerts.

Imaging trial in prostate cancer opens for recruitment

StockBot

416,823 posts

CU6 released this announcement to the ASX on 22 August 2022, 10:01. The announcement is marked as price sensitive, and is 3 page(s) in length and 293.07kb in size.

You can view all announcements from CU6 and see how they appear on a price chart on the announcements page.

At the date of this announcement, CU6 was 0.012% short sold according to ASIC data. It was ranked the 611th most shorted stock on the ASX. It is now ranked as the 37th most shorted stock on the ASX with 7.699% of total shares short sold as of the latest reported data (26 May 2026).

Other Recent Announcements from CU6
Cleansing Notice 28 June 2023, 13:19
Application for quotation of securities - CU6 28 June 2023, 13:13
Clarity Establishes US Center of Excellence for Research 28 June 2023, 9:08
Imaging trial in prostate cancer opens for recruitment 22 August 2022, 10:01
Notification regarding unquoted securities - CU6 16 August 2022, 12:05
Clarity expands manufacturing capabilities 11 August 2022, 9:45
Clarity and Evergreen expand TCT manufacturing 9 August 2022, 10:01
You must login or register to post a comment.

You must be logged in to post a reply.

Register to track CU6 and receive email alerts.